Package 50090-5101-1

Brand: bupropion hydrochloride (sr)

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-5101-1
Digits Only 5009051011
Product NDC 50090-5101
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1)

Marketing

Marketing Status
Marketed Since 2020-07-13
Brand bupropion hydrochloride (sr)
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "65817f64-2d82-4dc7-8a8a-cab01892826a", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["1801289"], "spl_set_id": ["994229b0-e190-49e3-83ce-6a2063f7335a"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-0)", "package_ndc": "50090-5101-0", "marketing_start_date": "20200713"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1)", "package_ndc": "50090-5101-1", "marketing_start_date": "20200713"}], "brand_name": "BUPROPION HYDROCHLORIDE (SR)", "product_id": "50090-5101_65817f64-2d82-4dc7-8a8a-cab01892826a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-5101", "generic_name": "Bupropion Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (SR)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206122", "marketing_category": "ANDA", "marketing_start_date": "20160817", "listing_expiration_date": "20261231"}